DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, to the Board of Directors Feb 11, 2015
DelMar Pharmaceuticals Completes Offer to Exchange Common Stock for Outstanding Warrants Feb 10, 2015
DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015 Jan 12, 2015
DelMar Pharmaceuticals' Promising New Data Support the Potential of VAL-083 to Meet Significant Unmet Medical Needs in the Treatment of Glioblastoma Multiforme Nov 17, 2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 as a Potential New Treatment in Glioblastoma at the Society of Neuro-Oncology Annual Meeting Nov 14, 2014
DelMar Pharmaceuticals Announces September 30, 2014 Results and Provides Corporate Update Nov 10, 2014
